title: Clinical experience with a monoclonal interleukin-2 receptor antibody (BT 563) for rejection therapy after orthotopic heart transplantation.
authors.affiliation: Department of Transplantation, Karl-Franzens University, Graz, Austria.
authors.forename: F
authors.initials: F
authors.lastname: Iberer
authors.forename: K H
authors.initials: KH
authors.lastname: Tscheliessnigg
authors.forename: M
authors.initials: M
authors.lastname: Freigassner
authors.forename: T
authors.initials: T
authors.lastname: Auer
authors.forename: R
authors.initials: R
authors.lastname: Kleinert
authors.forename: A
authors.initials: A
authors.lastname: Wasler
authors.forename: B
authors.initials: B
authors.lastname: Petutschnigg
authors.forename: H
authors.initials: H
authors.lastname: Müller
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001706:Biopsy; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D008875:Middle Aged; D015375:Receptors, Interleukin-2 / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; C079843:inolimomab